Inside nerve and heart cells, magnesium ions bind to specific sites on calcium channels to reduce calcium entry, which helps regulate how strongly cells respond to signals and prevents overstimulation.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether magnesium supplementation in humans with heart failure or hypertension reduces CaV1.2-mediated calcium overload and improves cardiac function, as measured by echocardiography and biomarkers.
A systematic review and meta-analysis of all randomized trials in adults with systolic heart failure comparing oral magnesium (300–400 mg/day) versus placebo for 6 months, with primary outcomes: LVEF change, NT-proBNP levels, and hospitalization rates.
Whether acute magnesium infusion reduces CaV1.2-mediated calcium transients in human cardiomyocytes during ischemia-reperfusion.
A double-blind RCT in 40 patients undergoing cardiac surgery, randomized to IV magnesium sulfate (10 mmol) or saline before reperfusion, with intracellular calcium measured via fluorescent probes in biopsied atrial tissue.
Whether low intracellular magnesium in lymphocytes predicts increased CaV1.2 activity and arrhythmia risk in patients with chronic kidney disease.
A prospective cohort of 500 patients with stage 4–5 CKD, measuring intracellular magnesium in peripheral lymphocytes via ion-selective microelectrodes and CaV1.2 activity via patch-clamp, followed for 5 years for ventricular arrhythmias.
Whether patients with Timothy syndrome (CaV1.2 gain-of-function mutation) have altered magnesium sensitivity in their cardiomyocytes compared to controls.
A case-control study comparing Mg2+i sensitivity of CaV1.2 currents in induced pluripotent stem cell-derived cardiomyocytes from 15 Timothy syndrome patients and 15 matched controls, using patch-clamp with controlled intracellular magnesium.
Whether serum magnesium correlates with intracellular magnesium and CaV1.2 current density in human atrial myocytes from patients undergoing cardiac surgery.
A cross-sectional study of 60 patients undergoing elective cardiac surgery, measuring serum magnesium, intracellular magnesium in biopsied atrial tissue, and CaV1.2 current density via patch-clamp, adjusting for age, sex, and medications.